Perrigo Company plc PRGO

Company Overview

Perrigo Company plc is a global consumer self-care and healthcare company focused primarily on over-the-counter (OTC) health and wellness products and consumer self-care solutions. The company operates in the consumer healthcare industry, with product categories spanning pain relief, upper respiratory, digestive health, nutrition, lifestyle, skin care, and oral care. Perrigo generates revenue largely through the manufacture and distribution of store-brand OTC pharmaceuticals, infant formula, and branded consumer health products sold through retailers, pharmacies, e-commerce channels, and healthcare providers. Its business model has historically emphasized affordable alternatives to national-brand healthcare products while also expanding into higher-margin branded self-care offerings.

Founded in 1887 in Michigan as a packager of home remedies, Perrigo evolved into one of the largest manufacturers of private-label OTC medicines in North America and later expanded internationally through acquisitions and portfolio diversification. The company restructured over time to sharpen its focus on consumer self-care, including divestitures of certain prescription pharmaceutical operations and investments in branded consumer health assets. Perrigo is publicly traded on the New York Stock Exchange under the ticker PRGO and is incorporated in Ireland, with operational roots and significant management presence in the United States.

Business Operations

Perrigo organizes its operations primarily through the Consumer Self-Care Americas and Consumer Self-Care International business segments. The Consumer Self-Care Americas segment includes U.S. and North American store-brand OTC products, infant nutrition, and branded wellness products distributed through major retail chains and e-commerce channels. The Consumer Self-Care International segment includes branded consumer healthcare products sold mainly across Europe, Australia, and other international markets. Revenue is generated through direct product sales to retailers, wholesalers, and distributors, with significant exposure to pharmacy and mass merchandise channels.

The company controls a broad manufacturing and distribution network supporting pharmaceutical-grade OTC production, supply-chain operations, and regulatory compliance capabilities. Perrigo maintains intellectual property, product formulations, manufacturing facilities, and established retailer relationships as key operational assets. Major subsidiaries and brands have included HRA Pharma, Compeed, Aco, NiQuitin, and Solpadeine. Strategic partnerships with retailers and distribution partners are central to the company’s private-label model, while acquisitions have strengthened its branded consumer healthcare presence internationally.

Strategic Position & Investments

Perrigo’s strategy centers on becoming a leading global self-care company focused on consumer-driven healthcare and wellness products. The company has prioritized portfolio optimization, operational efficiency, and expansion into higher-growth branded consumer healthcare categories. A major strategic milestone was the acquisition of HRA Pharma, which significantly expanded Perrigo’s European consumer healthcare footprint and added women’s health and specialty OTC products to its portfolio. The company has also continued investing in innovation within digestive health, allergy care, smoking cessation, and dermatological products.

Management has emphasized disciplined capital allocation, supply-chain resilience, and international expansion as long-term growth drivers. Perrigo has reduced exposure to lower-growth or non-core pharmaceutical businesses while investing in consumer-oriented health solutions and digital retail channels. Emerging focus areas include women’s health, self-care therapeutics, and preventive wellness products. Public filings and investor communications indicate ongoing investment in regulatory compliance, manufacturing modernization, and category innovation to support competitive positioning in both retailer-branded and branded OTC markets.

Geographic Footprint

Perrigo operates across multiple regions globally, with corporate incorporation in Ireland and significant operational headquarters functions in the United States. The company maintains a strong presence in North America through retailer partnerships and private-label OTC manufacturing. Internationally, Perrigo has expanded throughout Europe, where it markets branded consumer healthcare products across countries including France, the United Kingdom, Germany, and the Nordic region. The company also maintains commercial activities in parts of Australia and other international markets.

Its geographic strategy combines scale in the U.S. store-brand market with branded self-care growth internationally. Manufacturing, research, and distribution facilities are located across North America and Europe, enabling regional production and market responsiveness. Perrigo’s international influence increased substantially following acquisitions that broadened its European consumer healthcare portfolio and strengthened access to pharmacy and wellness distribution networks outside the United States.

Leadership & Governance

Perrigo’s leadership team oversees a strategy centered on consumer self-care growth, operational discipline, and portfolio transformation. Governance is directed through a board structure consistent with publicly traded multinational healthcare companies, with leadership emphasizing long-term shareholder value, category leadership in consumer wellness, and regulatory compliance. Strategic messaging from company filings and investor materials has consistently focused on consumer-centric healthcare, brand expansion, and global operational efficiency.

Key executives include:

• Patrick Lockwood-Taylor – President and Chief Executive Officer
• Eduardo Cordon-Carlyle – Executive Vice President and Chief Financial Officer
• Ron Janish – Executive Vice President, Global Operations and Supply Chain
• Katherine C. Serrano – Executive Vice President, Chief Legal Officer and Corporate Secretary
• Svend Andersen – Executive Vice President and President, Consumer Self-Care International
• Opal Leung – Executive Vice President and President, Consumer Self-Care Americas

Information in this overview has been verified against publicly available disclosures including SEC filings, company annual reports, investor presentations, and major financial and business reporting sources. Where operational or leadership information varies across reporting periods, the most recently available public disclosures were prioritized.